Return to homepagePandemic Pact

Vaccine platform recombinant measles viruses

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:1 publications

Grant number: HZI2021Z38

Grant search

Key facts

  • Disease

    N/A

  • Start & end year

    2021
    2026

  • Known Financial Commitments (USD)

    $601,096.08

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Research Location

    Germany

  • Lead Research Institution

    Paul-Ehrlich-Institut Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel

  • Research Priority Alignment

    N/A

  • Research Category

    14

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines.